Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies

Targeting Malignancies with Disulfiram (Antabuse): Multidrug Resistance, Angiogenesis, and Proteasome

(2011) B. Cvek   CURRENT CANCER DRUG TARGETS

The Ubiquitin-Proteasome System (UPS) and the Mechanism of Action of Bortezomib

(2011) Boris Cvek et al.   CURRENT PHARMACEUTICAL DESIGN

Antabuse (disulfiram) as a pilot case of nonprofit drug

(2010) Boris Cvek   INTERNATIONAL JOURNAL OF CANCER

NF-κB localization in multiple myeloma plasma cells and mesenchymal cells

(2010) Concetta Conticello et al.   LEUKEMIA RESEARCH

Captivating Bortezomib: An active but still mysterious drug

(2009) Francesco Di Raimondo et al.   LEUKEMIA RESEARCH

Cell Death

(2009) Richard S. Hotchkiss et al.   NEW ENGLAND JOURNAL OF MEDICINE

The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications

(2008) Amancio Carnero et al.   CURRENT CANCER DRUG TARGETS

Ni(II), Cu(II), and Zn(II) Diethyldithiocarbamate Complexes Show Various Activities Against the Proteasome in Breast Cancer Cells

(2008) Boris Cvek et al.   JOURNAL OF MEDICINAL CHEMISTRY